Patent Exhaustion and Licensing Strategies
Leveraging Recent Decisions for Structuring Patent Licenses and Resolving Litigation
Recording of a 90-minute premium CLE webinar with Q&A
This CLE course will provide guidance to counsel on the patent exhaustion doctrine and its impact on licensing and selling patented products. The panel will offer their experiences and outline best practices for addressing patent exhaustion issues for licensing.
- Recent developments in patent exhaustion
- Impact of recent decisions on patent licensing
- Best practices for addressing changes in patent licensing
The panel will review these and other key questions:
- Is a patent exhausted by the use of an unpatented component in a sold or licensed patented product?
- What are the implications of the doctrine of patent exhaustion for patent licenses?
- Under what circumstances could licensees be making royalty payments that aren't necessary?
Following the speaker presentations, you'll have an opportunity to get answers to your specific questions during the interactive Q&A.
McDermott Will & Emery
Ms. Kaiser focuses her practice on patent litigation and transactional patent matters, including prosecution,... | Read More
Ms. Kaiser focuses her practice on patent litigation and transactional patent matters, including prosecution, counseling and licensing. She is experienced in all aspects of patent-related intellectual property law, with an emphasis on litigation and chemical patent prosecution. She has worked extensively on patent disputes as well as disputes involving business interruption at industrial facilities.Close
Kevin E. Noonan, Ph.D.
McDonnell Boehnen Hulbert & Berghoff
Mr. Noonan's practice involves all aspects of patent prosecution, interferences, and litigation. He represents... | Read More
Mr. Noonan's practice involves all aspects of patent prosecution, interferences, and litigation. He represents pharmaceutical companies both large and small on a myriad of issues, as well as several universities in both patenting and licensing to outside investors. He is a founding author of the Patent Docs weblog, which focuses on biotechnology and pharmaceutical patent law.Close